WHO ICTRP trial

Primary Irritation Patch Test on Normal Skin (Single Application 24-hours…

CTRI/2025/09/093972 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2025/09/093972
Public title Primary Irritation Patch Test on Normal Skin (Single Application 24-hours occlusion)
Scientific title Evaluation of Dermatological Safety of Test Products by 24 Hours Patch Test under Complete Occlusion on Adult Healthy Human Participants with Normal Skin. - NIL
Primary sponsor Patanjali Foods Limited
Secondary sponsors Not Applicable
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Interventions Intervention1: Patanjali Aloe Soft Moisturizer: Neat, 0.04mg, single dose, topical application, 24 hr Intervention2: Patanjali Revogen + Intensive Repair Night Cream: Neat, 0.04mg, single dose, topical application, 24 hr Intervention3…
Registration date Jan 9, 2025
Target size 26
Secondary IDs C3B04977-PTL-A, Version: 01, Dated 22 Aug 25
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations